跳至主要内容
临床试验/NCT04250805
NCT04250805终止2 期

Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy

Centre Hospitalier Universitaire de Saint Etienne2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2020年10月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
17
试验地点
2
主要终点
Level of Pain

研究概览

简要总结

Gastrostomy is an intra-gastric nutritional enteral device that could be put in place by percutaneous technique under radiological guidance: allowing local anesthesia. However, there is no clear recommendation about local analgesia during this exam. Operator can chose Lidocaine with a short period of action, or Ropivacaine with a longer period of action. The association of these two drugs could enhance the analgesia post procedure. The main objective of this study is to decrease maximal pain felt during a twenty four hour stay, after a gastrostomy under percutaneous technique with radiological guidance.

详细描述

Gastrostomy is an intra-gastric nutritional enteral device, allowing the nutritional support for patients presenting oral feeding disorders. Gastrostomy could be put in place by different manners:

  • Chirurgical technique or endoscopy: with general anesthesia;
  • Percutaneous technique under radiological guidance: allowing local anesthesia. This last one is better tolerated by weak patients, and involves less complication.

However, there is no clear recommendation about local analgesia during this exam. Operator can chose Lidocaine with a short period of action, or Ropivacaine with a longer period of action.

The association of these two drugs could enhance the analgesia post procedure. Indeed, pain felt during the twenty four hours post procedure seems to be the most frequent adverse effect reported by patients.

Pain could decrease significantly when Ropivacaine is added to the reference Xylocaine. Ropivacaine had already proved its efficacy in association with other antalgics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Lidocaine and Ropivacaine

Experimental

Patients will receive Lidocaine and Ropivacaine during percutaneous gastrostomy under radiological guidance

干预措施: Lidocaine (Drug)

Lidocaine and Ropivacaine

Experimental

Patients will receive Lidocaine and Ropivacaine during percutaneous gastrostomy under radiological guidance

干预措施: Ropivacaine (Drug)

Lidocaine

Active Comparator

Patients will receive Lidocaine alone during percutaneous gastrostomy under radiological guidance

干预措施: Lidocaine (Drug)

结局指标

主要结局

Level of Pain

时间窗: 24 hours

Two points diminution for maximal pain felt during a twenty four hours after percutaneous gastrostomy under radiological guidance. It will be measured with a visual analogue scale starting at zero for no pain and ending at ten for maximal pain felt.

次要结局

  • Level of quality of life(10 days)
  • Level of Anxiety and Depression(10 days)
  • Level of satisfaction(10 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Trial Evaluating the Efficacy of the Combination of... | 临床试验